186 related articles for article (PubMed ID: 31764272)
1. Cost of Differentiated HIV Antiretroviral Therapy Delivery Strategies in Sub-Saharan Africa: A Systematic Review.
Roberts DA; Tan N; Limaye N; Irungu E; Barnabas RV
J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 3(Suppl 3):S339-S347. PubMed ID: 31764272
[TBL] [Abstract][Full Text] [Related]
2. Differentiated models of service delivery for antiretroviral treatment of HIV in sub-Saharan Africa: a rapid review protocol.
Long L; Kuchukhidze S; Pascoe S; Nichols B; Cele R; Govathson C; Huber A; Flynn D; Rosen S
Syst Rev; 2019 Dec; 8(1):314. PubMed ID: 31810482
[TBL] [Abstract][Full Text] [Related]
3. Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa.
Barker C; Dutta A; Klein K
J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21648. PubMed ID: 28770597
[TBL] [Abstract][Full Text] [Related]
4. Provider- and patient-level costs associated with providing antiretroviral therapy during the postpartum phase to women living with HIV in South Africa: A cost comparison of three postpartum models of care.
Cunnama L; Abrams EJ; Myer L; Phillips TK; Dugdale CM; Ciaranello AL; Zerbe A; Iyun V; MacQuilkan K; Daries V; Sinanovic E
Trop Med Int Health; 2020 Dec; 25(12):1553-1567. PubMed ID: 32959434
[TBL] [Abstract][Full Text] [Related]
5. Differentiated HIV care in sub-Saharan Africa: a scoping review to inform antiretroviral therapy provision for stable HIV-infected individuals in Kenya.
Hagey JM; Li X; Barr-Walker J; Penner J; Kadima J; Oyaro P; Cohen CR
AIDS Care; 2018 Dec; 30(12):1477-1487. PubMed ID: 30037312
[TBL] [Abstract][Full Text] [Related]
6. Annual cost of antiretroviral therapy among three service delivery models in Uganda.
Vu L; Waliggo S; Zieman B; Jani N; Buzaalirwa L; Okoboi S; Okal J; Borse NN; Kalibala S
J Int AIDS Soc; 2016; 19(5 Suppl 4):20840. PubMed ID: 27443270
[TBL] [Abstract][Full Text] [Related]
7. Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
Tagar E; Sundaram M; Condliffe K; Matatiyo B; Chimbwandira F; Chilima B; Mwanamanga R; Moyo C; Chitah BM; Nyemazi JP; Assefa Y; Pillay Y; Mayer S; Shear L; Dain M; Hurley R; Kumar R; McCarthy T; Batra P; Gwinnell D; Diamond S; Over M
PLoS One; 2014; 9(11):e108304. PubMed ID: 25389777
[TBL] [Abstract][Full Text] [Related]
8. Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda.
Babigumira JB; Castelnuovo B; Lamorde M; Kambugu A; Stergachis A; Easterbrook P; Garrison LP
BMC Health Serv Res; 2009 Oct; 9():192. PubMed ID: 19845963
[TBL] [Abstract][Full Text] [Related]
9. Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub-Saharan Africa: a rapid systematic review.
Long L; Kuchukhidze S; Pascoe S; Nichols BE; Fox MP; Cele R; Govathson C; Huber AN; Flynn D; Rosen S
J Int AIDS Soc; 2020 Nov; 23(11):e25640. PubMed ID: 33247517
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness and cost implications of task-shifting in the delivery of antiretroviral therapy to HIV-infected patients: a systematic review.
Mdege ND; Chindove S; Ali S
Health Policy Plan; 2013 May; 28(3):223-36. PubMed ID: 22738755
[TBL] [Abstract][Full Text] [Related]
11. Client and healthcare worker experiences with differentiated HIV treatment models in Eswatini.
Reidy W; Kambale HN; Hughey AB; Nhlengethwa TT; Tailor J; Lukhele N; Mthethwa S; Hettema A; Preko P; Rabkin M
PLoS One; 2022; 17(5):e0269020. PubMed ID: 35613146
[TBL] [Abstract][Full Text] [Related]
12. Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda.
Guthrie T; Muheki C; Rosen S; Kanoowe S; Lagony S; Greener R; Miot J; Balidawa H; Kiggundu J; Calnan J; Dejene S; Xulu T; Sigwebela N; Long LC
BMC Health Serv Res; 2022 Nov; 22(1):1315. PubMed ID: 36329450
[TBL] [Abstract][Full Text] [Related]
13. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
Cunnama L; Abrams EJ; Myer L; Gachuhi A; Dlamini N; Hlophe T; Kikuvi J; Langwenya N; Mthethwa S; Mudonhi D; Nhlabatsi B; Nuwagaba-Biribonwoha H; Okello V; Sahabo R; Zerbe A; Sinanovic E
Trop Med Int Health; 2018 Sep; 23(9):950-959. PubMed ID: 29956426
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients.
Nichols BE; Cele R; Lekodeba N; Tukei B; Ngorima-Mabhena N; Tiam A; Maotoe T; Sejana MV; Faturiyele IO; Chasela C; Rosen S; Fatti G
J Int AIDS Soc; 2021 Apr; 24(4):e25692. PubMed ID: 33838012
[TBL] [Abstract][Full Text] [Related]
15. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG
PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823
[TBL] [Abstract][Full Text] [Related]
16. Do differentiated service delivery models for HIV treatment in sub-Saharan Africa save money? Synthesis of evidence from field studies conducted in sub-Saharan Africa in 2017-2019.
Rosen S; Nichols B; Guthrie T; Benade M; Kuchukhidze S; Long L
Gates Open Res; 2021; 5():177. PubMed ID: 35310814
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis.
Smith JA; Sharma M; Levin C; Baeten JM; van Rooyen H; Celum C; Hallett TB; Barnabas RV
Lancet HIV; 2015 Apr; 2(4):e159-68. PubMed ID: 25844394
[TBL] [Abstract][Full Text] [Related]
18. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review.
Gourlay A; Birdthistle I; Mburu G; Iorpenda K; Wringe A
J Int AIDS Soc; 2013 Jul; 16(1):18588. PubMed ID: 23870277
[TBL] [Abstract][Full Text] [Related]
19. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.
Thomas R; Probert WJM; Sauter R; Mwenge L; Singh S; Kanema S; Vanqa N; Harper A; Burger R; Cori A; Pickles M; Bell-Mandla N; Yang B; Bwalya J; Phiri M; Shanaube K; Floyd S; Donnell D; Bock P; Ayles H; Fidler S; Hayes RJ; Fraser C; Hauck K;
Lancet Glob Health; 2021 May; 9(5):e668-e680. PubMed ID: 33721566
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.
Walensky RP; Ross EL; Kumarasamy N; Wood R; Noubary F; Paltiel AD; Nakamura YM; Godbole SV; Panchia R; Sanne I; Weinstein MC; Losina E; Mayer KH; Chen YQ; Wang L; McCauley M; Gamble T; Seage GR; Cohen MS; Freedberg KA
N Engl J Med; 2013 Oct; 369(18):1715-25. PubMed ID: 24171517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
